Holen Sie sich die Stockscreener-App
223.13
1.00%
-2.2429
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
AbbVie Inc Stock (ISIN: US00287Y1091) Faces Pressure Amid Valuation Concerns and Dividend Appeal - AD HOC NEWS
AbbVie CEO’s pay jumped 75% to $32.5M in second year at the helm - Crain's Chicago Business
AbbVie Stock: Is This Pharma Giant Still a Buy-or-Bail in 2026? - AD HOC NEWS
The Best Dividend Stocks to Buy and Hold Forever - The Motley Fool
AbbVie Inc. $ABBV Shares Sold by Van ECK Associates Corp - MarketBeat
Douglass Winthrop Advisors LLC Buys 9,022 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Cut by Bokf Na - MarketBeat
RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages - Insider Monkey
Antiviral Drugs Market Is Going to Boom Rapidly| AbbVie Inc., GSK plc, and Dr. Reddy's Laboratories Ltd. - openPR.com
AbbVie Reports Promising Results from Phase 1 Study of ABBV-295 - Yahoo! Finance Canada
How The Narrative For AbbVie (ABBV) Is Shifting On Immunology Growth And Competition Risks - Yahoo Finance
AbbVie’s ABBV-295 Obesity Data Sparks Fresh Interest In Valuation - simplywall.st
UCB's Bimzelx Outperforms AbbVie's Skyrizi in Psoriatic Arthritis Trial - GuruFocus
AbbVie’s Skyrizi beaten by UCB’s Bimzelx in psoriatic arthritis - Seeking Alpha
SageView Advisory Group LLC Buys 13,883 Shares of AbbVie Inc. $ABBV - MarketBeat
Kepler Cheuvreux Suisse SA Takes $7.54 Million Position in AbbVie Inc. $ABBV - MarketBeat
Mackenzie Financial Corp Sells 99,604 Shares of AbbVie Inc. $ABBV - MarketBeat
Scotiabank Reaffirms Their Buy Rating on AbbVie (ABBV) - The Globe and Mail
Franklin Resources Inc. Trims Holdings in AbbVie Inc. $ABBV - MarketBeat
Capital World Investors Sells 139,297 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (ABBV) gets downgraded to peer perform from outperform by Wolfe Research - MSN
AbbVie Obesity Drug ABBV-295 Hits Up to 9.8% Weight Loss in Early Trial - TechStock²
AbbVie’s GLP-1 challenger posts strong weight-loss results in early trial - Crain's Chicago Business
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Delcath Systems (DCTH) - The Globe and Mail
AbbVie Posts Encouraging Early-Stage Data For Amylin Analog ABBV-295 - Citeline News & Insights
Richard Bernstein Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV - MarketBeat
Capital Research Global Investors Sells 34,749 Shares of AbbVie Inc. $ABBV - MarketBeat
Capital International Investors Has $2.48 Billion Stake in AbbVie Inc. $ABBV - MarketBeat
Capital International Inc. CA Has $55.65 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Legal & General Group Plc Has $2.78 Billion Holdings in AbbVie Inc. $ABBV - MarketBeat
Bank of Montreal Can Raises Stock Position in AbbVie Inc. $ABBV - MarketBeat
William Blair and BMO Maintain Outperform on AbbVie Inc. (ABBV) March 2026 - Meyka
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295 - TipRanks
AbbVie says CEO Robert Michael's 2025 total compensation was $32.5 millionSEC filing - marketscreener.com
AbbVie (NYSE:ABBV) Shares Down 1% Following Insider Selling - MarketBeat
ICER to review AbbVie’s Parkinson’s disease drug - The Pharma Letter
AbbVie (ABBV) Reports Promising Phase 1 Results for Obesity Trea - GuruFocus
AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss - Benzinga
AbbVie sees promising early-stage data for weight loss asset ABBV-295 - Seeking Alpha
AbbVie Trial Updates Add Context To Valuation And Growth Outlook - Yahoo Finance
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Sienna Gestion Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Reports Promising Results from Phase 1 Study of AB - GuruFocus
Gubra's partner AbbVie reports positive phase 1 results for ABBV-295 - marketscreener.com
AbbVie reports Positive Phase 1 Multiple Ascending Dose Results for ABBV-295, a Long-Acting Amylin Analog - TradingView
AbbVie Inc. $ABBV Shares Purchased by Schroder Investment Management Group - MarketBeat
Swiss National Bank Trims Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults - Yahoo Finance
AbbVie Inc. $ABBV Shares Acquired by LGT Group Foundation - MarketBeat
Russell Investments Group Ltd. Increases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Jefferies Financial Group Inc. Sells 53,123 Shares of AbbVie Inc. $ABBV - MarketBeat
Streptococcus Market Is Going to Boom | AbbVie • Pfizer • Merck & Co. • GlaxoSmithKline - openPR.com
AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn’s Disease - Insider Monkey
First Trust Advisors LP Sells 1,007,670 Shares of AbbVie Inc. $ABBV - MarketBeat
Global drugmakers rush to boost US presence as tariff threat looms - Reuters
AbbVie Inc. (ABBV) is Drawing Interest from Investors: Key Information You Need to Know - Bitget
Vinva Investment Management Ltd Acquires 31,451 Shares of AbbVie Inc. $ABBV - MarketBeat
Natixis Advisors LLC Sells 4,569 Shares of AbbVie Inc. $ABBV - MarketBeat
Korea Investment CORP Acquires 188,587 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Rhenman & Partners Asset Management AB - MarketBeat
Gabelli Funds LLC Decreases Stake in AbbVie Inc. $ABBV - MarketBeat
B. Metzler seel. Sohn & Co. AG Grows Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Analysis: Performance, Financials, and OutlookNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Blair William & Co. IL Has $292.57 Million Position in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie (ABBV) Still Priced Attractively After Its Strong Multi Year Share Price Run - Yahoo Finance
AbbVie (NYSE:ABBV) SVP David Ryan Purdue Sells 5,230 Shares - MarketBeat
Evercore notes AbbVie Inc.’s (ABBV) Tremfya gains market share, but future earnings growth may be limited - MSN
AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
AbbVie (ABBV) Up 6.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Will AbbVie's Neuroscience Segment Continue to Aid Top Line in 2026? - Yahoo Finance
Edgar Lomax Co. VA Reduces Stock Position in AbbVie Inc. $ABBV - MarketBeat
Crossmark Global Holdings Inc. Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Berry Wealth Group LP Lowers Stake in AbbVie Inc. $ABBV - MarketBeat
Did Positive Phase 3 SKYRIZI Crohn’s Data Just Shift AbbVie’s (ABBV) Immunology Investment Narrative? - Yahoo Finance
0.89%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):